Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of acute ethanol on ventricular myofibrillary protein synthesis in vivo in normotensive and hypertensive rats.

Addiction biology·2016
Same author

Experimental heart muscle damage in alcohol feeding is associated with increased amounts of reduced- and unreduced-acetaldehyde and malondialdehyde-acetaldehyde protein adducts.

Addiction biology·2010
Same author

Relationship of acceptors for botulinum neurotoxins (types A and B) in rat CNS with the cholinergic marker, chol-I.

Neurochemistry international·2010
Same author

Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus.

Neuroscience·2005
Same author

Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease.

Neurology·2003
Same author

Single cell expression analysis--pharmacogenomic potential.

Pharmacogenomics·2002

Related Experiment Video

Updated: Jul 13, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Making sense of asthma.

P J Richardson

    Expert Opinion on Investigational Drugs
    |July 5, 2005
    PubMed
    Summary

    Genomic sequencing advancements by 2005 will identify new therapeutic targets for complex diseases. Antisense oligonucleotides can then target these gene products as novel treatments.

    Area of Science:

    • Genomics and Bioinformatics
    • Molecular Biology
    • Pharmacology

    Background:

    • The rapid sequencing of the human genome by 2005 presents a vast opportunity for identifying novel therapeutic targets.
    • Multifactorial diseases, such as asthma, involve complex gene product interactions that are increasingly becoming targets for therapeutic intervention.

    Discussion:

    • Antisense oligonucleotides (ASOs) offer a powerful tool to leverage genomic data for disease research.
    • ASOs can be employed to identify key gene products driving multifactorial diseases.
    • This approach facilitates the development of targeted therapies by modulating the activity of specific gene products.

    Key Insights:

    • Genomic sequencing is rapidly expanding the landscape of potential therapeutic targets.
    • Antisense oligonucleotide technology is crucial for validating and targeting these newly identified gene products.

    More Related Videos

    Methodology for Sputum Induction and Laboratory Processing
    13:28

    Methodology for Sputum Induction and Laboratory Processing

    Published on: December 17, 2017

    Asthma Detection Research Based on Voice Signal Processing and Machine Learning
    04:04

    Asthma Detection Research Based on Voice Signal Processing and Machine Learning

    Published on: July 22, 2025

    Related Experiment Videos

    Last Updated: Jul 13, 2026

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
    14:39

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

    Published on: November 4, 2010

    Methodology for Sputum Induction and Laboratory Processing
    13:28

    Methodology for Sputum Induction and Laboratory Processing

    Published on: December 17, 2017

    Asthma Detection Research Based on Voice Signal Processing and Machine Learning
    04:04

    Asthma Detection Research Based on Voice Signal Processing and Machine Learning

    Published on: July 22, 2025

  • This strategy holds promise for developing novel treatments for complex genetic disorders.

    • Outlook:

    • Future therapeutic strategies will increasingly rely on integrating genomic information with molecular targeting agents like ASOs.
    • The development of ASO-based therapeutics could revolutionize the treatment of multifactorial diseases.
    • Continued advancements in genomics and oligonucleotide synthesis will accelerate the discovery and application of targeted gene therapies.